Clinical research of urinary kallidinogenase united edaravone treating acute cerebral infarction

Objective: To investigate clinical effects of urinary kallidinogenase united edaravone treatment of acute cerebral infarction.Methods: 83 patients with acute cerebral infarction were randomly divided into observation group 43 cases and the control group of 40 patients.The control group were given edaravone on the basis of the symptomatic treatment;observation group were gaven urinary kallidinogenase treatment on base of control group,both two groups treated for 14 d.before treatment and 14 d after treatment to NIHSS evaluation of clinical efficacy.Results: The combination of the control group before treatment,14 d after the NIHSS scores were compared,the difference were statistically significant(P0.05);the treatment group compared with the control group after treatment,the difference was statistically significant(P0.05).The two groups were,respectively,efficiency and total efficiency,the difference was statistically significant(P0.05).Conclusion: Urinary kallidinogenase united edaravone for acute cerebral infarction,can improve neurological function in patients,and it is safe and effective.